Capricor Therapeutics to Present at Upcoming Scientific and Medical Conferences
SAN DIEGO, May 08, 2024 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare
diseases, today announced that the Company is scheduled to present at various upcoming scientific and medical conferences.
Event: |
American Society of Gene & Cell Therapy (ASGCT) 27th Annual Meeting (Baltimore, MD) |
Date: | May 7–11, 2024 |
Format: |
Oral Presentation/Abstract: Exosome-mediated intracellular delivery of arginase-1: a potential application for the treatment of Arginase-1 Deficiency |
Event: | Parent Project Muscular Dystrophy (PPMD) Cardiac Workshop III (Baltimore, MD) |
Date: | May 9–10, 2024 |
Format: | Panel: Industry perspectives on cardiac monitoring in DMD clinical trials |
Event: |
International Society of Extracellular Vesicles (ISEV) 2024 Meeting (Melbourne, Australia) |
Date: | May 9–12, 2024 |
Format: | Abstract: Targeted cargo delivery to mouse lower limb by exosomes carrying a muscle targeting moiety with intravenous injection |
Event: |
CureDuchenne 2024 FUTURES National Conference (Orlando, FL) |
Date: | May 23–26, 2024 |
Format: | Presentation: CAP-1002: an allogeneic cell therapy demonstrates disease modification in later-stage DMD patients: 24-month safety and efficacy results from the HOPE-2 open label extension |
Event: |
International Society for Cell & Gene Therapy (ISCT) 2024 Meeting (Vancouver, Canada) |
Date: | May 29–June 1, 2024 |
Format: | Oral Presentation/Abstract: Targeted delivery of ASO using exosomes leads to mouse dystrophin exon skipping |
Lesen Sie auch
The posters and/or abstracts will be made available on the publications section of the Capricor website following the conclusion of the meetings.
Diskutieren Sie über die enthaltenen Werte
Aktuelle Themen
Weitere Artikel des Autors
1 im Artikel enthaltener WertIm Artikel enthaltene Werte